Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
99 (46%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ROPINIROLE | 2MG | TABLET | Resolved | 2020-09-24 | 2020-11-12 | 125004 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Resolved | 2020-07-14 | 2021-04-15 | 120238 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Resolved | 2020-07-14 | 2021-04-15 | 120241 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Resolved | 2020-07-14 | 2021-04-15 | 120244 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2020-07-14 | 2023-04-28 | 120247 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2020-07-14 | 2023-04-28 | 120250 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2020-07-14 | 2022-03-26 | 120253 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2020-07-14 | 2021-05-06 | 120303 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2020-07-14 | 2021-05-06 | 120306 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2020-07-14 | 2021-05-06 | 120309 |
| TEVA-ROSUVASTATIN | 5MG | TABLET | Resolved | 2020-07-14 | 2021-03-04 | 120312 |
| TEVA-ROSUVASTATIN | 5MG | TABLET | Resolved | 2020-07-14 | 2021-03-04 | 120315 |
| TEVA-ROSUVASTATIN | 5MG | TABLET | Resolved | 2020-07-14 | 2021-07-09 | 120318 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2021-05-06 | 2021-06-03 | 138907 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2021-05-13 | 2022-03-18 | 139309 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2021-05-20 | 2021-06-24 | 139752 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Resolved | 2022-04-28 | 2022-05-06 | 159596 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Resolved | 2019-10-17 | 2019-12-19 | 96717 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2019-12-05 | 2020-01-30 | 100287 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2019-12-05 | 2020-01-30 | 100290 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CLOXACILLIN SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14018 |
| CLOXACILLIN SODIUM FOR INJECTION | 2G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14021 |
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
| EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Discontinued | 2020-10-22 | 2020-10-24 | 126906 |
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
| EPTIFIBATIDE INJECTION | 0.75MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14024 |
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 | ||
| EPTIFIBATIDE INJECTION | 2MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14027 |
| FLUDARABINE PHOSPHATE FOR INJECTION | 25MG | SOLUTION | Discontinued | 2025-10-22 | 2025-10-22 | 257579 |
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
| GEMCITABINE FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14033 |
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81337 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81344 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81330 | ||
| HYDROCORTISONE SODIUM SUCCINATE INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81347 | ||
| LEUCOVORIN CALCIUM INJECTION | 10MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14036 |
| LINEZOLID INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106173 |